The Effects of Chronic Administration of Inhibitors of Flavin and Quinone Amine Oxidases on Imidazoline I1 Receptor Density in Rat Whole Brain

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2003-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1196/annals.1304.040PMID 15028605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma amine oxidase activities in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase

  2005cited by this paper
• Effects of low- and high-dose tranylcypromine on [3H]tryptamine binding sites in the rat hippocampus and striatum

  2004cited by this paper
• Recent news related to substrates and inhibitors of plant amine oxidases.

  2003cited by this paper
• Modification of Noradrenaline Release in Pithed Spontaneously Hypertensive Rats by I1-Binding Sites in Addition to α2-Adrenoceptors

  2003cited by this paper
• Contribution of Individual Cytochrome P450 Isozymes to theO-Demethylation of the Psychotropic β-Carboline Alkaloids Harmaline and Harmine

  2003cited by this paper
• Is the catalytic mechanism of bacteria, plant, and mammal copper-TPQ amine oxidases identical?

  2003cited by this paper
• Agmatine oxidation by copper amine oxidase.

  2002cited by this paper
• Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine‐mediated blood pressure reaction

  2002cited by this paper
• Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

  2001cited by this paper
• beta-carboline binding to imidazoline receptors.

  2001cited by this paper
• Suppression of inducible nitric oxide generation by agmatine aldehyde: Beneficial effects in sepsis

  2001cited by this paper
• FAD-containing polyamine oxidases: a timely challenge for researchers in biochemistry and physiology of plants.

  2001cited by this paper
• Respective contributions of α‐adrenergic and non‐adrenergic mechanisms in the hypotensive effect of imidazoline‐like drugs

  2001cited by this paper
• Imidazoline receptors: possible involvement in the pathophysiology and treatment of depression

  2001cited by this paper
• Trace amines: Identification of a family of mammalian G protein-coupled receptors

  2001cited by this paper
• Biological significance of agmatine, an endogenous ligand at imidazoline binding sites

  2001cited by this paper
• Harmane produces hypotension following microinjection into the RVLM: possible role of I1‐imidazoline receptors

  2000cited by this paper
• Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration.

  2000cited by this paper
• Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzyme.

  2000cited by this paper
• Analysis of the pharmacological and molecular heterogeneity of I(2)-imidazoline-binding proteins using monoamine oxidase-deficient mouse models.

  2000cited by this paper
• Is agmatine a novel neurotransmitter in brain?

  2000cited by this paper
• Endogenous Indoleamines Demonstrate Moderate Affinity for I2 Binding Sites

  1999cited by this paper
• Modulation of MAO Activity by Imidazoline and Guanidine Derivatives

  1999cited by this paper
• Agmatine: An Endogenous Ligand at Imidazoline Receptors Is a Novel Neurotransmitter a

  1999cited by this paper
• Identification of the quinone cofactor in mammalian semicarbazide-sensitive amine oxidase.

  1998cited by this paper
• Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine.

  1998cited by this paper
• Endocytosis and recycling of G protein-coupled receptors.

  1997cited by this paper
• Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2‐imidazoline receptors in rat liver

  1997cited by this paper
• Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications

  1997cited by this paper
• A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates.

  1997cited by this paper
• Central cardiovascular actions of agmatine, a putative clonidine-displacing substance, in conscious rabbits.

  1997cited by this paper
• Agmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat.

  1996cited by this paper
• Agmatinase Activity in Rat Brain: A Metabolic Pathway for the Degradation of Agmatine

  1996cited by this paper
• Agmatine is not a good candidate as endogenous ligand for imidazoline sites of pancreatic B cells and vascular bed.

  1996cited by this paper
• Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects.

  1996cited by this paper
• Optimization of Radioligand Binding Assays for I1‐Imidazoline Sites fn1

  1995cited by this paper
• Further Studies on the Ex‐vivo Effects of Procarbazine and Monomethylhydrazine on Rat Semicarbazide‐sensitive Amine Oxidase and Monoamine Oxidase Activities

  1995cited by this paper
• Agmatine Is Widely and Unequally Distributed in Rat Organs

  1995cited by this paper
• Metabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptors.

  1995cited by this paper
• Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.

  1995cited by this paper
• The [3H]Tryptamine Receptor in Human Brain: Kinetics, Distribution, and Pharmacologic Profile

  1994cited by this paper
• Semicarbazide-sensitive amine oxidase and monoamine oxidase in rat brain microvessels, meninges, retina and eye sclera.

  1994cited by this paper
• Agonist‐specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems.

  1994cited by this paper
• Agmatine: an endogenous clonidine-displacing substance in the brain.

  1994cited by this paper
• Tryptamine Induces Phosphoinositide Turnover and Modulates Adrenergic and Muscarinic Cholinergic Receptor Function in Cultured Cerebellar Granule Cells

  1994cited by this paper
• The trace amines and their acidic metabolites in depression--an overview.

  1994cited by this paper
• Monoamine oxidase inhibition byl-deprenyl depends on both sex and route of administration in the rat

  1993cited by this paper
• Identification of topaquinone and its consensus sequence in copper amine oxidases.

  1992cited by this paper
• Phenylethylamine in the CNS: effects of monoamine oxidase inhibiting drugs, deuterium substitution and lesions and its role in the neuromodulation of catecholaminergic neurotransmission.

  1990cited by this paper
• Semicarbazide-sensitive amine oxidase (SSAO) of the rat aorta. Interactions with some naturally occurring amines and their structural analogues.

  1989cited by this paper
• The rational design of suicide substrates of amine oxidases.

  1986cited by this paper
• In vitro and in vivo inhibition by benserazide of clorgyline-resistant amine oxidases in rat cardiovascular tissues.

  1982cited by this paper
• THE EFFECTS OF CHRONIC REGIMENS OF CLORGYLINE AND PARGYLINE ON MONOAMINE METABOLISM IN THE RAT BRAIN

  1979cited by this paper
• [Inhibition of bacterial agmatinase by substrate analogs].

  1976cited by this paper
• Comparative effects of monoamine oxidase inhibitors on monoamine oxidase and diamine oxidase.

  1960cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• The Prescriber's Guide to the MAOI Diet-Thinking Through Tyramine Troubles.

  2022cites this paper
• Trace Amines and Their Relevance to Psychiatry and Neurology: A Brief Overview

  2017cites this paper
• Trace amines and their relevance to psychiatry and neurology: a brief overview / Eser aminler ve psikiyatri ve nöroloji ile ilişkisi: Kısa bir gözden geçirme

  2011cites this paper
• Rational drug discovery : structural studies of protein-ligand complexes

  2011cites this paper
• Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands.

  2009cites this paper
• Interactions of imidazoline ligands with the active site of purified monoamine oxidase A

  2007cites this paper
• The potential of trace amines and their receptors for treating neurological and psychiatric diseases.

  2007cites this paper
• Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators

  2004cites this paper
• Allosteric modulation of semicarbazide‐sensitive amine oxidase activities in vitro by imidazoline receptor ligands

  2004influential citation
• On the binding of monoamine oxidase inhibitors to some sites distinct from the MAO active site, and effects thereby elicited.

  2004cites this paper
• Imidazoline binding sites on receptors and enzymes: emerging targets for novel antidepressant drugs?

  2003cites this paper